STRS Ohio’s PMV Pharmaceuticals PMVP Stock Holding History

STRS Ohio’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100	Closed	–	–	2032
2022 Q4	$0	Hold	100	–	–	﹤0.01%	2049
2022 Q3	$1K	Hold	100	–	–	﹤0.01%	2000
2022 Q2	$1K	Hold	100	–	–	﹤0.01%	2026
2022 Q1	$2K	Hold	100	–	–	﹤0.01%	2126
2021 Q4	$2K	Hold	100	–	–	﹤0.01%	2174
2021 Q3	$2K	Sell	100 -6,000	-98%	-$192K	﹤0.01%	2223
2021 Q2	$208K	Buy	6,100 +2,800	+85%	+$93.5K	﹤0.01%	1809
2021 Q1	$108K	Hold	3,300	–	–	﹤0.01%	1928
2020 Q4	$202K	Buy	+3,300	New	+$129K	﹤0.01%	1739

Other funds holding PMVP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

STRS Ohio's PMVP Position: Q1 2023 in Review

STRS Ohio sold out of PMV Pharmaceuticals (PMVP) in Q1 2023, closing a stake of 100 shares.

STRS Ohio first reported a position in PMVP in Q4 2020 and held it in 9 quarters. The position peaked at $208K in Q2 2021. 111 funds tracked by Wall St. Rank hold PMVP as of Q1 2023.

STRS Ohio reported no remaining PMV Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
STRS Ohio sold 100 PMV Pharmaceuticals shares in Q1 2023.
STRS Ohio first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 9 quarters.
STRS Ohio's PMV Pharmaceuticals position peaked at $208K in Q2 2021.
111 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2023.

Based on STRS Ohio's 13F filing for Q1 2023, filed 27 Apr 2023.